BioCentury
ARTICLE | Financial News

Niemann-Pick play Vtesse adds $17M to series A

July 25, 2016 7:00 AM UTC

Vtesse Inc. (Gaithersburg, Md.) raised $17 million from insiders in an extension of its series A round, bringing the total to $42 million. Last year, Vtesse was spun out of Orphan drug accelerator Cydan Development Inc. (Cambridge, Mass.) with $25 million.

All of the company's existing investors participated, including Alexandria Venture Investments, Bay City Capital, Lundbeckfond Ventures, New Enterprise Associates (NEA) and Pfizer Venture Investments. ...